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Abstract 
Background: Dengue is an arboviral infection that classically presents with fever, joint pain, headaches, skin flush 
and morbilliform rashes. The incidence of neurological symptoms and complications in dengue varies from 1 to 25 % 
that include encephalopathy, Guillain–Barre syndrome (GBS), acute motor weakness, seizures, neuritis, hypokalaemic 
paralysis, pyramidal tract signs, and a few more. Dengue fever as an antecedent infection in GBS is uncommon.
Case presentation: A 34-years-old Sri Lankan Sinhalese male presented with fever, headache and myalgia of 3 days 
and developed leucopenia and thrombocytopenia without evidence of haemoconcentration. The diagnosis of den-
gue fever was confirmed as he had positive dengue NS1 antigen test on the third day of fever. He made full recovery 
and was discharged after 4 days of hospital stay. Six days later, he presented with history of acute flaccid weakness of 
both lower limbs and upper limbs which was of progressive ascending nature. The electromyography had evidence 
of demyelinating neuropathy and cerebrospinal fluid showed albuminocytological dissociation. Subsequently, IgM for 
dengue virus was positive.
Conclusion: Dengue is endemic in Sri Lanka. Post dengue Guillain–Barre syndrome is a potential neurological com-
plications of this infection.
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Background
Dengue is a common human arbovirus infection globally 
[1, 2]. The World Health Organization (WHO) estimates 
an annual incidence of approximately 100 million infec-
tions, with approximately 500,000 people with dengue 
haemorrhagic fever (DHF) requiring hospitalization, and 
a large proportion of them being children [2].
As the incidence of dengue and DHF is increasing, 
unusual manifestations are on the rise, although they 
are being under reported due to the lack of awareness 
[3]. Neurological manifestations so far reported include 
depression, convulsions, encephalopathy, encephalitis, 
aseptic meningitis, intracranial haemorrhage, intracra-
nial thrombosis, myelitis, mononeuropathies, polyneu-
ropathies, hemifacial spasm, peripheral facial paralysis 
and Guillain–Barre syndrome (GBS) [3–5]. GBS or acute 
inflammatory demyelinating polyradiculopathy (AIDP) 
is a post infectious ascending, usually demyelinating, 
polyradiculoneuropathy accompanied by areflexia, motor 
paralysis, and elevated cerebro spinal fluid (CSF) total 
protein without pleocytosis [5–9].
Well established associations with GBS are recent 
infections with Campylobacter jejuni, Cytomegalo virus, 
Epstein–Barr virus, Mycoplasma pneumonia, HIV. But 
dengue fever (DF) as an antecedent infection in GBS is 
uncommon [5, 10, 11]. Several previous reports have 
described GBS in patients with dengue [3, 5, 12]. Most 
of these cases were children and a few cases of post-den-
gue GBS in adults [5]. Herewith we present an adult case 
of possible post-dengue GBS in Sri Lanka and this case 
calls for special attention because the dengue infection 
remains a serious public health problem in many coun-
tries and the actual incidence of neurological complica-
tions is not well reported.
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Case presentation
A 34-years-old Sri Lankan Sinhalese man was admitted 
in August 2014, with pain and numbness of both lower 
limbs for 3  days, followed by weakness of both lower 
limbs with numbness and pain of upper limbs for 1 day. 
On admission he was not able to walk as usual and had 
no difficulty in breathing or coughing. He could pass 
urine without any difficulty and did not have constipa-
tion. Ten days ago, he had been admitted to the same 
hospital with high grade continued fever of 3 days dura-
tion with generalized body ache, headache, nausea and 
retro-orbital pain. Then he had leucopenia, thrombocy-
topenia and positive dengue NS1 antigen in the blood. 
He had uneventful dengue fever without haemoconcen-
tration and was discharged after 3 days in the hospital.
On examination, he was conscious, well oriented and 
had normal vital parameters. Cardiovascular, respira-
tory and abdominal system examinations were normal. 
The limb examination revealed hypotonia with reduced 
power in all four limbs, the lower limbs being most 
affected. The tendon reflexes were absent even with 
reinforcement. Sensory modalities were intact. His neck 
muscle power was normal and cranial nerves were nor-
mal. Provisionally, the diagnosis of ascending progressive 
polyneuropathy suggestive of GBS was made.
He had normal full blood count, erythrocyte sedimen-
tation rate, C-reactive protein, serum electrolytes, renal 
function tests, liver function tests and chest X-ray. Serol-
ogy for Hepatitis B, HIV were negative. Dengue IgM was 
positive. However an electrophysiological study revealed 
severe demyelinating polyneuropathy in the lower and 
upper limbs. Cerebro spinal fluid study showed albumi-
nocytological dissociation [CSF appearance was clear, 
red blood cell: nil, 2 lymphocytes, protein 235 mg/dl, glu-
cose 4.3 mmol/l (random blood sugar was 6.4 mmol/l).]. 
Gram stain CSF showed no bacteria. Finally a diagnosis 
of GBS associated with dengue fever was confirmed.
Therapeutically, plasmapheresis was carried out 
according to the protocol of the North American trial 
in which a total of 200–250  ml/kg is exchanged over 
7–10  days. Meanwhile, on the second day, the limbs 
weakness increased and he developed left side lower 
motor type seventh cranial nerve palsy with positive 
Bell’s sign (Figs.  1, 2). But other cranial nerves, neck 
muscle power and respiration were normal. After two 
cycles of plasmapheresis on fourth day of hospital stay, 
he developed right side lower motor seventh cranial palsy 
with positive Bell’s sign (Fig. 3). After four cycles of plas-
mapheresis, there was little improvement of upper limbs 
weakness. After fifth cycle of plasmapheresis, his upper 
limbs improved further and right sided facial nerve weak-
ness showed some improvement. After seventh cycle of 
plasmapheresis, his right facial nerve palsy completely 
improved and upper limbs and lower limbs showed sig-
nificant improvement. Left side seventh nerve palsy 
showed significant improvement and other cranial nerves 
were normal. He developed neither urinary nor bowel 
incontinence. He did not develop autonomic symptoms 
such as resting tachycardia, gustatory sweating. With 
continued supportive measures, the patient made a sig-
nificant recovery after 20  days of hospital stay and was 
referred to a rehabilitation hospital for further care. One 
month later we reviewed patient and by then he could 
walk alone. His facial nerves weakness also showed sig-
nificant improvement (Figs. 4, 5).
Fig. 1 Second day of illness—left lower motor facial nerve palsy 
showing deviation of mouth to right
Fig. 2 Second day of illness—partial closure of left eye with positive 
Bell’s sign and complete closure of right eye
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Discussion
Dengue, an arboviral infection that classically presents 
with fever, joint pains, headaches, skin flush and morbilli-
form rashes. Dengue viruses (DENV) belong to the fam-
ily Flaviviridae and there are four serotypes of the virus 
referred as DENV-1, DENV-2, DENV-3 and DENV-4 
[2]. All four serotypes can cause the full spectrum of dis-
ease including subclinical infection to a mild self limiting 
disease, dengue fever and severe disease that may be fatal 
including the dengue haemorrhagic fever/dengue shock 
syndrome (DHF/DSS).
Around 2.5 billion people around the world live in dengue 
endemic countries and are at risk of developing DF/DHF. 
Dengue is endemic in most countries of the South East Asia 
region where the detection of all four serotypes has now 
rendered these countries hyperendemic [2, 13, 14]. Dengue 
viral infections have become endemic in Sri Lanka since the 
mid 1960s, and since then the infections have increased dra-
matically over the past three decades [4, 13, 15].
We described this case scenario of GBS that had been 
preceded by a proven episode of dengue fever. Both 
episodes were not severe in their natural history as the 
patient did not develop plasma leak during the dengue 
infection and respiratory failure during subsequent GBS. 
The patient made recovery which was probably due to 
early use of plasmapheresis. Neurological manifestation 
associated with dengue fever has been reported from 25 
different countries from Asia–Pacific, Americas, Medi-
terranean and Africa [5]. The involved ages had ranged 
from 3  months to 60  years in both sexes, being more 
common in children [5]. The incidence of neurological 
symptoms and complications among dengue patients 
varied from 1 to 25  % of all dengue admissions [2, 5, 
12]. These manifestation included encephalopathy, GBS, 
acute motor weakness, seizures, neuritis, hypokalaemic 
paralysis, pyramidal tract signs, etc. [2, 5, 16].
There are a few previous reports that described GBS in 
patients with dengue particularly in adults. Gupta P et al. 
Fig. 3 Fourth day of illness—showing bilateral lower motor facial 
nerve palsy with partial closure of both eyes and positive Bell’s sign
Fig. 4 One month later—patient is attempting to raise his eyebrows 
showing improvement; right > left
Fig. 5 One month later—patient is attempting to show his teeth 
showing improvement; right > left
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[17] reported a case of post-dengue GBS in a 24-year old 
unmarried male presenting with acute flaccid weakness 
of the lower limbs following a febrile illness of 3 days. The 
PCR for dengue was positive and IgM and IgG antibod-
ies for DENV were found positive. The patient had been 
treated with intravenous human immunoglobulins and 
had a quick and complete recovery [17]. Similarly, Nee 
Kong Chew et al. [18] reported two cases of post-dengue 
GBS. The first case was a 43-year old woman with GBS 
presenting with the weakness of all four limbs and res-
piratory distress. She required assisted ventilation and 
immunomodulation treatment. The second case was a 
51-year old man with bilateral facial weakness and numb-
ness of extremities without motor weakness and recov-
ered [18]. In 2012, Qureshi NK et al. reported a case of 
GBS following dengue fever in an adult patient. The case 
was a 39-year old female presented with acute flaccid 
weakness of both upper and lower limbs which devel-
oped in ascending and progressive fashion following a 
febrile illness of 3 days. She had positive IgM for DENV 
and was treated with intravenous immunoglobulins. In 
all these case reports, the onset of GBS occurred after 
recovery from the initial dengue infection similar to the 
present case report. The mechanism for post-dengue 
GBS is not fully understood. There is evidence that this 
is an immune-mediated neurological disease [17, 18]. 
Pro-inflammatory substances that participate in immune 
response to DENV such as TNF, complement, inter-
leukins may have important role in the pathogenesis of 
GBS [19]. Immune response evoked by dengue fever 
may in turn cross-react with peripheral nerve compo-
nents because of sharing of cross-reactive epitopes. This 
immune response can be directed towards the myelin or 
axon of peripheral nerves [20].
Several randomized clinical trials indicate that plasma 
exchange is more effective than supportive treatments 
in reducing the median time taken for recovery in GBS 
[5, 18]. Intravenous immunoglobulin (IVIg) appears as 
effective as plasma exchange and IVIg may be preferred 
because of its low side effect profile and ease of admin-
istration [5, 18]. Corticosteroids alone do not alter the 
outcome of GBS, and there is insufficient evidence to 
support their use in combination with immunoglobulin 
[5, 18]. Other treatments such as CSF filtration remain 
experimental and unproven [5]. Our patient was treated 
with seven sessions of plasma exchange and showed 
gradual improvement.
In our patient, the presence of a positive dengue-spe-
cific IgM antibody test indicates acute dengue illness. 
Neurological manifestations, pattern of electrophysi-
ological study and the typical CSF findings were consist-
ent with the diagnosis of GBS. Development of GBS in 
about 10  days after the initial manifestation of dengue 
support the association of these two conditions. Verma 
et  al. shows that the patient presents with neurological 
syndromes like myelitis, myositis, GBS etc., dengue infec-
tion should be kept in differential diagnosis and should 
be ruled out especially during dengue outbreaks [21].
Conclusion
Dengue is an endemic infection in Sri Lanka causing 
great impact on the health of the island nation. Other 
than encephalopathy, its various neurological complica-
tions have rarely been addressed. Acute flaccid paralysis 
or GBS is an uncommon neurological sequel of dengue 
fever and has not been previously reported from Sri 
Lanka. Though there are well established preceding 
infective agents causing GBS, preceding dengue fever as 
aetiological factor for GBS is not well documented. Thus 
our case report, as some shown in previous reports, call 
attention to the possibility that GBS may occur in asso-
ciation with dengue.
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